Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Nature Clinical Practice. Rheumatology|February 3, 2009
Do the benefits of alendronate for premenopausal women on high-dose glucocorticoids outweigh the risks?William F Lems, Piet P GeusensArthritis Research & Therapy|October 17, 2009
Measuring metacarpal cortical bone by digital x-ray radiogrammetry: a step forward?Piet P Geusens, Willem F LemsCurrent Opinion in Rheumatology|January 19, 2016
Osteoporosis and osteoarthritis: shared mechanisms and epidemiologyPiet P Geusens, Joop P van den BerghNature Reviews. Rheumatology|January 18, 2012
Osteoporosis, frailty and fracture: implications for case finding and therapyJoop P van den Bergh, Tineke A van Geel, Piet P GeusensCurrent Osteoporosis Reports|June 22, 2010
Assessment of individual fracture risk: FRAX and beyondJoop P W van den Bergh, Tineke A C M van Geel, Willem F Lems, et al.Journal of Evaluation in Clinical Practice|September 22, 2006
Review and evaluation of the Dutch guidelines for osteoporosisPiet P Geusens, Willem F Lems, Harald J J Verhaar, et al.Maturitas|January 8, 2010
Individualizing fracture risk predictionTineke A C M van Geel, Joop P W van den Bergh, Geert-Jan Dinant, et al.Maturitas|October 8, 2010
Clinical fractures cluster in time after initial fractureTineke A C M Laurs-van Geel, Jacqueline R Center, Piet P Geusens, et al.Current Osteoporosis Reports|November 30, 2010
Optimal use of vitamin D when treating osteoporosisJoop P W van den Bergh, Sandrine P G Bours, Tineke A C M van Geel, et al.European Journal of Endocrinology|January 29, 2009
Measures of bioavailable serum testosterone and estradiol and their relationships with muscle mass, muscle strength and bone mineral density in postmenopausal women: a cross-sectional studyTineke A C M van Geel, Piet P Geusens, Bjorn Winkens, et al.Pageof 4